Sign in
4

Changes in Ownership

Emmaus Life Sciences, Inc. Filed Acc 0001615774-17-006925

Chief Executive Officer acquired 7,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Carpenter George C IV Chief Executive Officer 2017-11-13 Grant or award +7,500 39,708 D
Loading xslF345X03/s108241_form4.xml…